Support and Resistance Levels
Past performance
About Curis Lifesciences Ltd Curis Lifesciences Limited is a pharmaceutical manufacturing company with over seven years of experience in its field. Originally established as a partnership firm in 2010 under the name "M/s Loreto Pharmaceuticals," it transitioned into a private limited company in 2016 and later became a public limited company in August 2024. The company operates an extensive manufacturing facility in Sanand, Ahmedabad, Gujarat, which serves both domestic and international markets.
The facility is equipped with the capacity to produce a wide range of pharmaceutical products, including 138 crore tablets, 15.75 crore capsules, 1,080 kiloliters of oral liquid, 270 tons of external preparations, and 45 tons of sterile ophthalmic ointments annually. Its product portfolio encompasses tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. Curis Lifesciences works primarily on a product-to-product basis with various marketers, demonstrating robust collaborations in the pharmaceutical sector.
The company boasts an established clientele featuring notable names like J.B. Chemical & Pharmaceuticals Limited, Centurion Healthcare Private Limited, Venus International, and Angle Biogenics Private Limited, among others. Its strategic location in Sanand GIDC-II offers seamless accessibility, facilitating efficient operations and distribution.
Curis Lifesciences is now planning an Initial Public Offering (IPO) to issue up to 22,50,000 equity shares with a face value of Rs. 10 each, aimed at raising capital to support its growth trajectory. This IPO presents a potential investment opportunity for traders looking to participate in the expanding pharmaceutical manufacturing industry.